All News

My prostate cancer has come back and stronger, but so have I.

Certain patients with lung cancer who have EGFR exon 20 insertion mutations may have a new treatment option, which welcomes a new “milestone.”

An expert spoke with CURE® about the next steps for patients recently diagnosed with prostate cancer and the types of treatments they may receive.

Although many hate drinking the prep for colonoscopies, I view it as a privilege.

The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

A patient received a dose of the novel menin inhibitor, ziftomenib, plus Xospata in a phase 1 trial for patients with AML.

This poem was written in hope that those experiencing multiple myeloma, or other cancers, will find solace in knowing that advancements in treatments are being made every day, and a positive attitude with caregiver acceptance and support will prolong one’s days for a productive life.

As a three-time cancer survivor, I wonder: are my roots damaged or resting to find their way?

An expert gives an overview of common endocrine-related side effects that premenopausal women with breast cancer may experience — and what can be done to address them.

Attending follow-up appointments as blood cancer survivors can help prevent more dangerous outcomes, including secondary cancers, an expert told CURE®.

Even though multiple myeloma had devastating effects on my collapsed lungs, singing has helped regain my sense of strength and resilience.

From Jason Kelce honoring the team trainer who has been diagnosed with cancer to deaths in the sports reporting and music world, here’s what’s happening in the oncology space this week.

When I had cancer for the third time, I spent afternoons resting in my room, watching and listening to the sounds of nature.

The Food and Drug Administration approved Brukinsa plus Gazyva for patients with relapsed or refractory follicular lymphoma who have undergone two or more prior lines of therapy.

The time after a cancer diagnosis can be stressful, as the care team needs to balance unnecessary treatment delays with getting the therapeutic plan right.

After having early-stage breast cancer and stage 3B lung cancer, I'm choosing to give back. Here's how.

The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder cancer, the agency has announced.

The CURE® 2024 Lung Cancer Special Issue provides insight into the ever-changing innovation in the lung cancer space.

Survivors of rhabdomyosarcoma may be at higher risk for poorer psychological outcomes, that radiation therapy and smoking may worsen.

The Food and Drug Administration approved Besponsa for pediatric patients aged 1 and older with relapsed or refractory CD22-positive, B-cell precursor ALL.

The Food and Drug Administration green lit a first-in-human phase 1 clinical study of Innocell, a vaccine for the treatment of stage 3 and 4 ovarian cancer.

When I first received my diagnosis of colon cancer, I felt so negative. So, I started positive self-talk and it's changed my outlook for the better.

In some patients with rare cancers, certain strains of gut bacteria could boost responses to immunotherapy combinations, researchers established.

When people tell me I have metastatic cancer, I don't let their doom and gloom stop me — I'm going to bloom like a flower.

Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed.

This special issue of CURE Lung Cancer takes a deeper dive into ALK-positive non-small cell lung cancer.

When I told my friends I started feeling better during cancer treatment, they were all so confused.